Compare CDXS & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDXS | AOMR |
|---|---|---|
| Founded | 2002 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.3M | 210.5M |
| IPO Year | 2008 | 2019 |
| Metric | CDXS | AOMR |
|---|---|---|
| Price | $2.29 | $8.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.08 |
| AVG Volume (30 Days) | ★ 756.7K | 154.3K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.18% |
| EPS Growth | 43.82 | ★ 53.85 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $138,590,000.00 | N/A |
| Revenue This Year | $7.73 | N/A |
| Revenue Next Year | $14.24 | $1.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $0.96 | $7.96 |
| 52 Week High | $3.87 | $10.14 |
| Indicator | CDXS | AOMR |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 62.42 |
| Support Level | $1.57 | $8.73 |
| Resistance Level | $2.71 | $8.91 |
| Average True Range (ATR) | 0.17 | 0.21 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 1.44 | 88.48 |
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in first and second lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rate and credit cycles. The company operates in a single operating segment, which is to acquire, invest in, and finance mortgage-related assets.